WW International WW 深 滬
已收盤 07-31 16:00:00 美东时间
14.36
+0.460
+3.31%
華盛通- 最 高14.42
- 今 開13.94
- 成交量 8.32万股
- 最 低 13.415
- 昨 收 13.90
- 總市值 1.44亿
- 52周最高 41.57
- 市盈率 靜 0.14
- 換手率 0.83%
- 52周最低 8.365
- 委 比 73.51%
- 總股本 999.88万
- 歷史最高 46.949
- 量 比 0.44
- 振 幅 7.23%
- 歷史最低 8.365
- 每 手 1
- 風險率 8.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call
WW International, Inc. (Weight Watchers) will release its Q2 2026 results after market close on August 5, 2026. A conference call to discuss the results will be held at 5:00 p.m. ET the same day, with a webcast available on corporate.ww.com under Events and Presentations. Weight Watchers is the global leader in science-backed weight management, offering integrated solutions including medication, technology, and community support. The company has ...
07-23 20:05
WW International Partners With Sam's Club To Combine Expert Guidance, Nutrition Counseling, Affordable Healthy Foods And Trusted Pharmacy Services
Sam's Club Plus members may receive a complimentary three-month Weight Watchers Core membership, while all Sam's Club members can save up to 50% on select Weight Watchers programs Collaboration connects medication support, nutrition, healthy food choices and trusted pharmacy care in one seamless exp...
07-09 20:06
Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community
Weight Watchers collaborates with FlavCity to launch a limited-edition Whipped Lemonade protein smoothie powder with 25g of protein and 10g of collagen, available via FlavCity's platforms. They also introduce the Summer Strength Club, a 10-week program featuring workouts, nutrition tips, and community support, led by FlavCity's Bobby Parrish and Weight Watchers' Holly Rilinger, aimed at helping participants build strength and maintain momentum th...
07-08 13:00
慧轻健康医疗通过联邦医疗保险GLP-1过渡计划建立GLP-1类药物获取渠道
核心事件：WW国际公司（纳斯达克股票代码：WW，慧俪轻体）宣布旗下Med+项目将为符合条件的联邦医保参保人提供支持，协助其通过联邦医保GLP-1过渡计划获取减重...
06-30 21:28
WW International's Weight Watchers Med+ Will Support Medicare Members Seeking Access To GLP-1s Under The Medicare GLP-1 Bridge Program
Through the Medicare GLP-1 Bridge Program, eligible beneficiaries purchase GLP-1 medications for weight loss, including Zepbound®, KwikPen®, Foundayo®, and Wegovy® pen and pill, for $50 per month. The program will run from July 1, 2026 through December 31, 2027. In addition to prescribing medication...
06-30 20:04
WW International And CheqUp Expand Partnership To Deliver Behavioural And Clinical Support For People On Weight Management Journey In UK
The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss. CheqUp becomes the dedicated partner for weight-loss treatment, including access to CheqUp's clinical service in the UK, mirroring the integrated clini...
06-17 04:03
Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK
Weight Watchers and CheqUp have expanded their partnership in the UK, integrating clinical and behavioral weight management services. Weight Watchers UK members can now access CheqUp's medical weight loss programs, while CheqUp members continue to benefit from Weight Watchers' app and Core+ program, including the GLP-1 Companion Programme. This collaboration aims to provide a holistic approach to weight loss, combining medical treatment with beha...
06-16 20:01
Hims & Hers Health 在慧俪轻体和礼来的竞争中受挫，首席执行官称赞Anthropic的人工智能突破有望改变医疗行业格局
赫姆斯与赫尔斯健康公司（Hims & Hers Health, Inc.，股票代码：HIMS）股价隔夜下跌1%，投资者权衡其人工智能发展雄心及来自慧俪轻...
06-15 15:24
慧俪轻体扩大GLP - 1药物业务版图，礼来探索肾病新疗法
慧俪轻体国际公司宣布其慧俪轻体平台可通过礼来公司的礼来直达数字医疗平台使用，扩大了获取GLP - 1减肥药物及临床和行为支持服务的途径，这符合慧俪轻体“医疗 ...
06-15 15:14
Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies
Weight Watchers joins LillyDirect for GLP-1 access as Eli Lilly signs a kidney disease research pact with Ascidian worth up to $1.9 billion.
06-05 00:17
